SAMANTHA PUSHCHAK: Open Payments
NPI 1043863285 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,593 in 89 payments from 26 companies in 2025. Trend: 2023 $2,454 · 2024 $2,456 · 2025 $2,593
Food & beverage: $2,593
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $365 |
| Gilead Sciences, Inc. | 9 | $318 |
| PFIZER INC. | 11 | $296 |
| ABBVIE INC. | 10 | $265 |
| Collegium Pharmaceutical, Inc. | 9 | $149 |
| HEARTFLOW, INC. | 2 | $148 |
| SCPHARMACEUTICALS INC. | 3 | $138 |
| Globus Medical, Inc. | 1 | $127 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Edwards Lifesciences Corporation | 2 | $96 |
Products named: AIRSUPRA, VRAYLAR, Belbuca, FFRct, Yeztugo, FUROSCIX, Senza, ZAVZPRET.
Industry payments across CO — which companies pay providers there.
